XTLB
XTL Biopharmaceuticals
XTLB
XTLB
5 hedge funds and large institutions have $728K invested in XTL Biopharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$38.3K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$19.5K |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$110K |
| 2 |
CTC
2
Central Trust Company
Jefferson City,
Missouri
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $559K | 198,888 | – | – |
|
|
2
Morgan Stanley
New York
| $110K | 39,171 | -40,371 | -51% |
|
|
3
Citadel Advisors
Miami,
Florida
| $38.3K | 13,631 | +13,631 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $19.5K | 6,954 | +6,900 | +12,778% |
|
5
BNP Paribas Financial Markets
Paris,
France
| $843 | 300 | – | – |
|
|
CTC
6
Central Trust Company
Jefferson City,
Missouri
| – | – | -200 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|